They need to reduce working capital, $25m of inventory on sales of $5om is absurd, if they can unlock $15m of that they would be net cash with enough to support future growth. Financial management 101.
perhaps there is a risk of a write down on the value of inventory?
- Forums
- ASX - By Stock
- PAL
- Ann: Palla Pharma Investor Presentation - FY19 Results & Outlook
Ann: Palla Pharma Investor Presentation - FY19 Results & Outlook, page-14
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)